Overview of This Study:

This study involved four major activities in estimating the current size of the Chiral Chromatography Column Market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.

Driver: Increasing R&D investments in the pharmaceutical and biotechnology industry

Chromatography is a versatile separation technique that is used across many industries such as biopharmaceutical & pharmaceutical, food & beverage, oil & petroleum, environmental testing, and agriculture & chemical. Pharmaceutical and biotechnology companies are investing significant amounts of their revenue in research to come up with breakthrough protein-related products to meet the growing needs of the healthcare sector. Chromatography, spectroscopy, PCR, flow cytometry, and NGS are common technologies used in proteomic research. Moreover, pharmaceutical and biotechnology companies are increasingly adopting these technologies for protein separation and identification during drug discovery and development.

Restraints: Lack of skilled professionals

The proper use of analytical technologies such as chromatography, PCR, and NGS requires expertise with relevant experience and knowledge. Various technological innovations in the chiral chromatography columns market are increasing the need for skilled professionals who can effectively operate chiral chromatography columns. For instance, an inconsistent column packing can result in low purity levels and product yield, which would, in turn, impact the quality of the final product. Moreover, the selection of the right chromatography technique (specific to a given task) plays a crucial role in the purification process. The lack of knowledge regarding the right choice of technique incurs several direct and indirect expenses and increases the time to market the drugs.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

Revenue Growth Impact:

The chiral chromatography column market size is projected to grow from an estimated USD 99 million 2020 to USD 123 million by 2025, at a CAGR of 4.5% during the forecast period.

Major Growth Driving Factors:

Market growth is driven largely by factors, such as increasing R&D investments in the pharmaceutical and biotechnology industry, and increasing importance of chromatography tests for drug approvals. Moreover, growth opportunities in emerging countries as well as green chromatography are expected to present avenues of growth for market players.

Challenges: Inadequate infrastructure for research in emerging countries

Adequate infrastructure for research, coupled with a skilled workforce, financial support, and basic research laboratories, are the key prerequisites for the use of chiral chromatography techniques for research. However, emerging countries in Asia (such as India, Indonesia, and the Philippines), the Middle East (such as Oman, Iraq, and UAE), and Africa lack the required infrastructure. For instance, in India, of the 4,168 private laboratories in the state of Kerala, only 7% have the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation or ISO certification.

Opportunities: Growth opportunities in emerging countries

Many developing economies, such as India, China, Brazil, Russia, Taiwan, and South Korea, offer high-growth opportunities for major market players in the life science instrumentation market owing to the increasing growth opportunities for analytical instruments. Although the adoption of advanced technologies is low in developing countries, their huge population base and increasing research activities, especially in India and China, are expected to offer a sustainable market for life science instruments. Furthermore, with the increasing number of greenfield projects and rising capital expenditure on infrastructure development, these countries are offering potential growth avenues for market players.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

North America is expected to be the largest market during the forecast period.

US and Canada are the major countries considered for the study of the chiral chromatography column market. North America has a diverse and well-established R&D infrastructure, with rapid adoption of chromatography techniques among end-user industries. North America accounted for the largest share of 37.3% of the chiral chromatography columns market in 2019. A number of factors, such as increasing drug development activities, the availability of government funding for life science R&D, high adoption of technologically advanced solutions, and a large number of ongoing clinical research studies are driving the growth of the North American chiral chromatography columns market.